Your browser doesn't support javascript.
loading
Metabolic Recycling Enhances Proliferation in MYC-Transformed Lymphoma B Cells.
Zhang, Cissy; Hoang, Giang; Attarwala, Nabeel; Cooper, Arthur J L; Asaka, Ryoichi; Le, Anne.
Afiliación
  • Zhang C; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
  • Hoang G; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
  • Attarwala N; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
  • Cooper AJL; Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY, 10595, USA.
  • Asaka R; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
  • Le A; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.
Adv Biol (Weinh) ; 7(2): e2200233, 2023 02.
Article en En | MEDLINE | ID: mdl-36417583
Relapses negatively impact cancer patient survival due to the tumorigenesis ability of surviving cancer cells post-therapy. Efforts are needed to better understand and combat this problem. This study hypothesized that dead cell debris post-radiation therapy creates an advantageous microenvironment rich in metabolic materials promoting the growth of remaining live cancer cells. In this study, live cancer cells are co-cultured with dead cancer cells eradicated by UV radiation to mimic a post-therapy environment. Isotopic labeling metabolomics is used to investigate the metabolic behavior of cancer cells grown in a post-radiation-therapy environment. It is found that post-UV-eradicated dead cancer cells serve as nutritional sources of "off-the-shelf" and precursor metabolites for surviving cancer cells. The surviving cancer cells then take up these metabolites, integrate and upregulate multiple vital metabolic processes, thereby significantly increasing growth in vitro and probably in vivo beyond their intrinsic fast-growing characteristics. Importantly, this active metabolite uptake behavior is only observed in oncogenic but not in non-oncogenic cells, presenting opportunities for therapeutic approaches to interrupt the active uptake process of oncogenic cells without affecting normal cells. The process by which living cancer cells re-use vital metabolites released by dead cancer cells post-therapy is coined in this study as "metabolic recycling" of oncogenic cells.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Recurrencia Local de Neoplasia Límite: Humans Idioma: En Revista: Adv Biol (Weinh) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfoma de Células B / Recurrencia Local de Neoplasia Límite: Humans Idioma: En Revista: Adv Biol (Weinh) Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania